0001631569-26-000026
SEC filingCHCT delivered strong earnings growth in Q1 FY2026, with net income up 60.2% and diluted EPS more than doubling, reflecting improved operating leverage despite modest revenue growth of 4.8%.
Revenue for Q1 FY2026 totaled $31.5 million, an increase of 4.8% compared to $30.1 million in Q1 FY2025. This growth reflects the ongoing contribution of contractual rents across CHCT’s healthcare real estate portfolio. Net income rose significantly to $2.5 million, a 60.2% increase over $1.6 million in the prior-year quarter. The outsized growth in net income relative to revenue suggests improved operating leverage, though the authoritative financial packet does not provide line-item detail on expense drivers beyond interest expense. Diluted EPS increased to $0.07 from $0.03, a 133.3% year-over-year gain — attributable entirely to higher net income and a stable diluted share count, as no new equity was issued during the quarter.